What is Exagen Inc.'s price / sales?

Exagen Inc. (XGN) reported price / sales of 1.1× in Q1 2026.

How has Exagen Inc.'s price / sales changed year-over-year?

Exagen Inc.'s price / sales decreased by 6.9% year-over-year, from 1.1× to 1.1×.

What is the long-term trend for Exagen Inc.'s price / sales?

Over 5 years (2020 to 2025), Exagen Inc.'s price / sales has grown at a -16.4% compound annual growth rate (CAGR), from 5.1× to 2.1×.

What does price / sales mean?

Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.

Exagen Inc. XGN Price / sales

Price / sales at other companies

Labcorp HoldingsLH

1.6×+0.1×

Quest DiagnosticsDGX

1.9×+0.1×

Avalo TherapeuticsAVTX

176.3×+173×

CareDxCDNA

2.2×-0.7×

Bio-Rad LaboratoriesBIO

2.9×+0.2×

RevvityRVTY

3.4×-1.2×

Other financials

Income statement

See full

Revenue$17.3M+11.7%

Gross profit$10.2M+11.9%

Operating income-$3.4M-1.5%

Net income-$4.0M-5.7%

EPS (diluted)-$0.17+15.0%

Balance sheet

See full

Cash & equivalents$21.7M+90.6%

Total debt$27.1M+15.8%

Total equity$14.4M+125%

Total assets$52.0M+28.9%

Cash flow

See full

Operating cash flow-$10.4M+2.4%

CapEx$228.0K+102%

Free cash flow-$10.6M+1.3%

Valuation

See full

Market cap$112.34M-26.5%

Enterprise value$117.78M-20.3%

Profitability

See full

Gross margin58.3%-1.0pp

Operating margin-20.6%-2.9pp

Net margin-29.5%+2.5pp

FCF margin-27.5%—

Returns & leverage

See full

Return on equity-193.6%+355pp

Debt / equity1.9×-1.8×

Current ratio3.5×+1.1×

Where this comes from

Calculated from Exagen Inc.’s reported figures.

market cap/total revenue=1.1×

Based on the most recent quarter.

The official record: Exagen Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Exagen Inc.'s price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Exagen Inc.'s price / sales?: Exagen Inc. (XGN) reported price / sales of 1.1× in Q1 2026.
How has Exagen Inc.'s price / sales changed year-over-year?: Exagen Inc.'s price / sales decreased by 6.9% year-over-year, from 1.1× to 1.1×.
What is the long-term trend for Exagen Inc.'s price / sales?: Over 5 years (2020 to 2025), Exagen Inc.'s price / sales has grown at a -16.4% compound annual growth rate (CAGR), from 5.1× to 2.1×.
What does price / sales mean?: Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.